RYTMEC
Live / Allowed — Notice of allowance issued (as of 10 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 31 Jul 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99312514
- Mark type
- Stylized text
- Filed
- 31 Jul 2025
- Published for opposition
- 13 Jan 2026
- Attorney of record
- John L. DuPre'
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals and pharmaceutical preparations for use in the treatment of central nervous system diseases and disorders; Pharmaceuticals and pharmaceutical preparations for use in the treatment of neurodevelopmental diseases and disorders; Pharmaceuticals and pharmaceutical preparations for use in the treatment of Rett syndrome diseases and disorders; Pharmaceuticals and pharmaceutical preparations for use in intrathecally administered gene therapy treatments
Owner
- Taysha Gene Therapies, Inc., Dallas, TX, US
- Taysha Gene Therapies, Inc., Dallas, TX, US
Prosecution history
- 10 Mar 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 13 Jan 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 13 Jan 2026 — PUBLISHED FOR OPPOSITION
- 07 Jan 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 15 Dec 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 15 Dec 2025 — ASSIGNED TO EXAMINER
- 31 Jul 2025 — APPLICATION FILING RECEIPT MAILED
- 31 Jul 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 31 Jul 2025 — NEW APPLICATION ENTERED